Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest BioView Ltd. Stories

2012-11-28 08:30:30

REHOVOT, Israel, November 28, 2012 /PRNewswire/ -- BioView Ltd. (TASE: BIOV), announced today that they have entered into an agreement with Abbott to collaborate on the development of an automated scanning solution to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in patients with advanced non-small cell lung cancer (NSCLC). Under terms of the agreement BioView will perform the appropriate studies to obtain regulatory approval for its Duet Automated...

2012-07-09 02:25:31

REHOVOT, Israel and PARIS, July 9, 2012 /PRNewswire/ -- BioView Ltd. (TASE: BIOV) and ScreenCell, a privately-held company, today jointly announced the signing of a commercial collaboration agreement for Bioview's Automated Cell Imaging Systems for imaging of CTC's isolated with ScreenCell's Cyto Kit (R). Dr. Alan Schwebel, President and CEO of BioView, views this agreement as a unique combination of two innovative technologies, one designed by ScreenCell to isolate rare...

2012-02-21 07:30:00

REHOVOT, Israel, February 21, 2012 /PRNewswire/ -- Iris Sample Processing from Westwood, MA - a division of IRIS International, Inc. (NASDAQ GS:: IRIS) and BioView Ltd, (TASE: BIOV [http://www.tase.co.il/TASEEng/Management/GeneralPages/SimpleSearchResult.htm?objectId=&objectType=&securityType=&searchTerm=biov ] ) from Rehovot, Israel, announced that they have entered into an agreement appointing BioView as one of the worldwide distributors for Iris Sample...

2009-12-14 05:00:00

ALISO VIEJO, Calif. and REHOVOT, Israel, Dec. 14 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd. (TASE: BIOV) today jointly announced that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung cancer. The test, which uses a patient's sputum and was originally developed at the...

2008-09-24 09:00:48

REHOVOT, Israel, September 24 /PRNewswire-FirstCall/ -- BioView Ltd, from Rehovot, Israel, reported today results of its internal clinical trial of the non-invasive diagnostic test under development for early detection of lung cancer. In the trial a total of 76 sputum samples were collected from four groups of patients: 1. Healthy individuals that never smoked 2. Heavy smokers with no signs of lung cancer 3. Early stage lung cancer patients (Stage 1) 4. Advanced stage lung...